The opioid addiction and overdose epidemic continues to take the lives of too many Americans. Of the nearly 64,000 overdose deaths reported in 2016, almost two-thirds involved a prescription or illicit opioid. Yale faculty have confronted the crisis in...
Heart failure is the leading cause of death and disability in the United States, costing healthcare systems worldwide more than $30 billion annually. Current approaches to treatment are limited by crude clinical assessments of the disease. In a new study...
When individuals with HIV are released from prison, they have difficulty obtaining care and are often unable to adhere to their HIV medications and maintain viral suppression. Relapse to opioid use often occurs quickly after release from prison or jail...
A serum developed by Yale researchers reduces infection from malaria in mice, according to a new study. It works by attacking a protein in the saliva of the mosquitos infected with the malaria parasite rather than the parasite itself. If the novel...
A Yale-led research team made a startling discovery while investigating the effect of bacteria on viral infections. When they applied a common topical antibiotic to mice before or shortly after infection with herpes and other viruses, they found that the...
To promote scientific progress and diversity in clinical research, Yale School of Medicine and the U.S. Food and Drug Administration have agreed to collaborate on a range of far-reaching science-based initiatives. Through trainings, fellowships,...